Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of...
-
BOSTON, MA and PROVIDENCE, RI, June 02, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach...
-
New York, April 29, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the launch of its nationwide campaign focused on amyotrophic lateral sclerosis (ALS) during ALS...
-
New York, April 08, 2025 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) and the International Association of Fire Fighters (IAFF) are celebrating over 70 years of partnership by launching...
-
PathMaker Neurosystems Announces Issuance of Three Patents Protecting the Use of Company’s Proprietary Neuromodulation Technology in ALS
-
PathMaker Welcomes Pritish Shah to Board of Directors
-
PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator® Device in ALS which will take place at BIDMC in Boston
-
New York, USA, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Latest Published 4 Rare Neurological Disorders Market Reports by DelveInsight: Amyotrophic Lateral Sclerosis, Developmental and Epileptic...
-
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
-
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has...